Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
Clinical trial NCT04292340 · UNKNOWN
Trial details
- NCT number
- NCT04292340
- Sponsor
- Shanghai Public Health Clinical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.